![Herbal analogue of ibuprofen](assets/cache/images/mirovye-novosti/01-09/09-12-400x400-f5c.jpg)
Scientists believe that some parts of Psychotria insularum can be used in traditional pharmaceutical production
![Mononucleosis may increase the risk of multiple sclerosis](assets/cache/images/mirovye-novosti/01-09/03.12-400x400-491.jpg)
Infectious mononucleosis experience in childhood is now considered as a factor that increases the risk of multiple sclerosis
![Influenza may increase the risk of Parkinson's disease](assets/cache/images/mirovye-novosti/01-09/30-11-400x400-91e.jpg)
A large study has found the increased risk of Parkinson's disease due to seasonal infection
![A new drug approved for hormonal therapy](assets/cache/images/mirovye-novosti/01-09/26-11-2021-400x400-9e3.jpg)
The American regulator has used long-acting corticotropin injections in the treatment of some chronic autoimmune diseases
![Metformin is effective against cancer](assets/cache/images/mirovye-novosti/01-09/22-11-400x400-ce9.jpg)
An antidiabetic drug can help to treat a rare type of brain and spinal cord cancer
![Bisphosphonates in the treatment of osteoporosis](assets/cache/images/mirovye-novosti/01-09/1280x800-conference.dc4-400x400-c92.jpg)
On October 20-21 in Kiev, the IV Scientific International Symposium "Diseases of the musculoskeletal system and age" was held
![Lysine is able to destroy staphylococcus](assets/cache/images/mirovye-novosti/569/15-11-400x400-f25.jpg)
A biotech company has designed an innovative enzyme – a recombinant exebacase to destroy staphylococcus aureus
![MASTER CLASS](assets/cache/images/mirovye-novosti/569/111-400x400-7cc.png)
On October 29, 2021, a master class "Simple and complex diagnosis" was held online within the All-Ukrainian Professional Respiratory School
![UMSA - the century of innovative approaches and scientific achievements](assets/cache/images/mirovye-novosti/569/bigstock-speaker-at-business-conference-64962394-400x400-95b.jpg)
On October 8, 2021, Ananta Medicare took part in the All-Ukrainian interdisciplinary scientific and practical conference
![A multiple sclerosis drug has been tested](assets/cache/images/mirovye-novosti/01-09/11.11-400x400-062.jpg)
MSD has published Phase II study data suggesting the candidate is effective to treat exacerbations of relapsing multiple sclerosis